Plus Therapeutics reported 0.6 in PE Price to Earnings for its fiscal quarter ending in March of 2026.





Pe Change Date
Baxter International 20.35 131.6 Sep/2026
Dr.Reddys Laboratories 35.92 2.77 Sep/2026
Haemonetics 25.44 8.08 Sep/2026
Northwest Biotherapeutics 11.67 6.93 Sep/2022
Sanofi 22.34 3.38 Sep/2026
Sun Pharmaceuticals 37.28 1.1 Sep/2026
Teva Pharmaceutical Industries 18.7 5.9 Sep/2026